Synthesis of dibenzyl iminodiacetic derivatives as potential inhibitors of HIV-1 aspartyl protease

European Journal of Medicinal Chemistry

Volumn 33, Issue 2, 1998, Pages 155-160

  Abalain, Cécile ^a   Langlois, Michel ^a  

^a CNRS   (France)

Author keywords

Aspartyl protease; Enzymatic inhibitor; HIV 1 protease; Hydroxylamine; Nitrone

Indexed keywords

2,2' DIBENZYLIMINODIACETIC ACID DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASPARTIC PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

CHIRALITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN EXPRESSION; SHORT SURVEY; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 0032006474     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80041-X     Document Type: Article

References (17)

1. [1] Norbek D.W., Ann. Rep. Med. Chem. 25 (1989) 149-158.
2. [2] Abdel-Meguid S.S., Med. Res. Rev. 6 (1993) 731-778.
3. [3] Erickson J., Neidhart D.J., VanDrie J., Kempf D.J. et al., Science 249 (1990) 527-533.
4. [4] Babine R.E., Zhang N., Jurgens A.R., Schow S.R. et al., Bioorg. Med. Chem. Lett. 2 (1992) 541-546.
5. [5] Kempf D.J., Norbeck D.W., Codacovi L.M., Wang X.C. et al., J. Med. Chem. 33 (1990) 2687-2689.
6. [6] Bone R., Vacca J.P. Anderson P.S., Holloway M.K., J. Am. Chem. Soc. 113 (1991) 9382-9384.
7. [7] Askin D., Wallace M.A., Vacca J.P., Reamer R.A. et al., J. Org. Chem. 57 (1992) 2771-2773.
8. [8] Babine R.E., Zhang N., Schow S.R., Jirousek M.R., Bioorg. Med. Chem. Lett. 3 (1994) 1589-1594.
9. [9] Babine R.E., Zhang N., Schow S.R., Xu Z. et al., Bioorg. Med. Chem. Lett. 4 (1994) 583-588.
10. [10] Langlois M., Quintard D., Abalain C., Eur. J. Med. Chem. 29 (1994) 639-647.
11. [11] Effenberger F., Burkarg U., Liebigs Ann. Chem. (1986) 334-358.
12. [12] Fenestra R.W., Stokkingreef R.J.F., Nivard R.J.F., Ottenheijm H.C.J., Tetrahedron 44 (1988) 5583-5595.
13. [13] Burger V.K., Fehn J., Thenn W., Angew. Chem. 85 (1973) 542-543.
14. [14] Beckett A.H., Coutts R.T., Ogunbona F.A., Tetrahedron 29 (1973) 4189-4193.
15. [15] Bücchi G., Luk K.C., Kobbe B., Townsend J.M., J. Org. Chem. 42 (1977) 244-246.
16. [16] Hirel Ph.H., Parker F., Boiziau J. et al., Antiviral Chem. Chemother. 1 (1990) 9-15.
17. [17] Murthy K.H.M., Winborne E.L., Minnich M.D., Culp J.S., Debouk C., J. Biol. Chem. 267 (1992) 22770-22778.